The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 118.00
Ask: 122.00
Change: 7.50 (6.67%)
Spread: 4.00 (3.39%)
Open: 117.50
High: 120.50
Low: 117.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Joint poultry vaccine development licencing deal

19 Nov 2018 07:00

ECO Animal Health Group plc

(AIM: EAH)

ECO Animal Health and University of Georgia sign poultry vaccine development licencing deal

ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, is pleased to announce that it has entered into a licensing deal with the Poultry Diagnostic & Research Center, College of Veterinary Medicine at the University of Georgia (UGA).

This deal, at a cost of just over $1 million in phased payments of eight quarterly instalments over a two year period, allows ECO to license research related innovations leading to the development of potential vaccines in the field of Mycoplasma gallisepticum, a bacterium that can cause severe respiratory disease in poultry. A joint steering committee will meet monthly to review data, monitor progress and reach go/no-go decisions.

Peter Lawrence, Chairman of ECO Animal Health Group plc said, “Mycoplasma-related illnesses in poultry can be financially devastating to commercial poultry producers with global losses estimated at more than £500 million annually. We are delighted to have entered into this collaboration with UGA and expect that further innovative developments will follow”.

Professor Naola Ferguson-Noel, a researcher in the Poultry Diagnostic & Research Center said, “Although Mycoplasma control programs are often based on biosecurity, early detection, quarantine and elimination of positive flocks, vaccination can be a very effective option in some circumstances. I do think a vaccine is within reach.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900

-----------------------------------------------------

About ECO Animal Health Ltd

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.

About University of Georgia

UGA is an American public, flagship, and comprehensive research university based in Athens, Georgia. It has been ranked in the Top 10 of all USA universities for licensing deals for the past decade and, to date, more than 700 UGA products and technologies have been introduced to the marketplace.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181118005025/en/

Copyright Business Wire 2018

Date   Source Headline
5th Mar 20187:00 amBUSRegulatory Approval
1st Feb 20181:33 pmBUSBlock listing Interim Review
1st Feb 20181:24 pmBUSTotal Voting Rights
23rd Jan 20183:37 pmBUSDirector/PDMR Shareholding
22nd Jan 20187:00 amBUSRegulatory Approval
5th Jan 20187:00 amBUSCirc re. Change of Nominated Adviser
19th Dec 20177:00 amBUSRegulatory Approval
13th Dec 20177:00 amBUSRegulatory Approval
6th Dec 20177:00 amBUSHalf-year Report
1st Dec 20177:00 amBUSDirectorate change
2nd Nov 20173:20 pmBUSBlock listing Interim Review - Replacement
25th Sep 20173:42 pmBUSHolding(s) in Company
22nd Sep 20178:53 amBUSHolding(s) in Company
20th Sep 20178:04 amBUSAGM Statement
4th Sep 20173:12 pmBUSTotal Voting Rights
23rd Aug 20178:30 amBUSDirector/PDMR Shareholding
21st Aug 20177:00 amBUSRegulatory Approval
15th Aug 20174:48 pmBUSDirector/PDMR Shareholding
14th Aug 20177:00 amBUSRegulatory Approval
1st Aug 20177:00 amBUSCirc re. Block listing return
1st Aug 20177:00 amBUSTotal Voting Rights
24th Jul 20177:00 amBUSRegulatory Approval
19th Jul 201711:05 amBUSDoc re. Block Listing Application
11th Jul 201710:11 amBUSHolding(s) in Company
11th Jul 201710:04 amBUSHolding(s) in Company
3rd Jul 20172:26 pmBUSNotice of AGM
30th Jun 20172:56 pmBUSDirector/PDMR Shareholding
30th Jun 20177:00 amBUSFinal Results
5th Jun 20177:00 amBUSRegulatory Approval
15th May 20177:00 amBUSTrading Statement
13th Mar 20179:32 amBUSHolding(s) in Company
2nd Feb 20178:29 amBUSHolding(s) in Company
20th Jan 20173:59 pmBUSHolding(s) in Company
20th Jan 20173:56 pmBUSHolding(s) in Company
12th Jan 20173:05 pmBUSDirector/PDMR Shareholding
9th Jan 20177:00 amBUSRegulatory Approval
19th Dec 201610:42 amBUSDirector/PDMR Shareholding
12th Dec 20167:00 amBUSHalf-year Report
5th Dec 20167:00 amBUSRegulatory Approval
2nd Nov 201610:06 amBUSHolding(s) in Company
1st Nov 201610:23 amBUSCirc re.Appointment of Joint Broker
31st Oct 201612:55 pmBUSDirector/PDMR Shareholding
31st Oct 20169:00 amBUSHolding(s) in Company
19th Oct 20167:00 amBUSRegulatory Approval
13th Oct 20164:24 pmBUSDirector/PDMR Shareholding
6th Oct 20167:46 amBUSDirector/PDMR Shareholding
28th Sep 20163:44 pmBUSDirector/PDMR Shareholding
16th Sep 201612:47 pmBUSAGM Statement
16th Sep 20167:00 amBUSAGM Statement
15th Sep 20163:57 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.